Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 GeneticVariation disease CLINVAR
Entrez Id: 6473
Gene Symbol: SHOX
SHOX
0.010 Biomarker disease BEFREE We investigated the relationship between SHOX mutations, height deficit, and Madelung deformity to determine the contribution of SHOX haploinsufficiency to the LWD and Turner syndrome (TS) phenotypes. 11739418 2001
Entrez Id: 284004
Gene Symbol: HEXD
HEXD
0.010 Biomarker disease BEFREE TS disease is a GM2 gangliosidosis attributed to the deficiency of the lysosomal enzyme beta-hexosaminidase A (HexA) (beta-N-acetylhexosaminidase, EC ). 11923278 2002
Entrez Id: 10724
Gene Symbol: OGA
OGA
0.010 Biomarker disease BEFREE TS disease is a GM2 gangliosidosis attributed to the deficiency of the lysosomal enzyme beta-hexosaminidase A (HexA) (beta-N-acetylhexosaminidase, EC ). 11923278 2002
Entrez Id: 6692
Gene Symbol: SPINT1
SPINT1
0.010 Biomarker disease BEFREE Treatment with HAI + SYS significantly improved the survival profile of TS+ patients. 12560427 2003
Entrez Id: 6768
Gene Symbol: ST14
ST14
0.010 Biomarker disease BEFREE Treatment with HAI + SYS significantly improved the survival profile of TS+ patients. 12560427 2003
Entrez Id: 7298
Gene Symbol: TYMS
TYMS
0.040 AlteredExpression disease BEFREE Patients with different TS tumour expression showed a similar percentage of Objective Clinical Response, OR (40% vs. 28% of OR in low and high TS-expressing tumours, respectively, p=ns); also, patients with different Topo-I tumour expression did not show a different probability of OR (39% vs. 29% of OR in high and low Topo-I expressing tumours, respectively; p=ns). 15197779 2004
Entrez Id: 56994
Gene Symbol: CHPT1
CHPT1
0.010 AlteredExpression disease BEFREE We can conclude that high TS tumour expression seems not to preclude a clinical activity for 5-FU/CPT-11 polichemotherapy in advanced colorectal cancer patients; furthermore, clinical response and prognosis of colorectal cancer patients treated with 5-FU/CPT-11 regimen do not differ in tumours with different TS or Topo-I expression. 15197779 2004
Entrez Id: 79947
Gene Symbol: DHDDS
DHDDS
0.010 AlteredExpression disease BEFREE We can conclude that high TS tumour expression seems not to preclude a clinical activity for 5-FU/CPT-11 polichemotherapy in advanced colorectal cancer patients; furthermore, clinical response and prognosis of colorectal cancer patients treated with 5-FU/CPT-11 regimen do not differ in tumours with different TS or Topo-I expression. 15197779 2004
Entrez Id: 265
Gene Symbol: AMELX
AMELX
0.010 Biomarker disease BEFREE The method was applied to the analysis of Y-chromosome sequences (amelogenin gene, AMELX/Y-loci) in peripheral lymphocytes and gonadal tissues in Y-positive Turner's syndrome (TS) patients. 15262449 2004
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 Biomarker disease CTD_human Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. 15454078 2004
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 CausalMutation disease CLINVAR Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. 15454078 2004
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 GeneticVariation disease UNIPROT Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. 15454078 2004
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 Biomarker disease GENOMICS_ENGLAND Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. 15454078 2004
Entrez Id: 2688
Gene Symbol: GH1
GH1
0.030 Biomarker disease BEFREE The age at diagnosis of 242 girls with Turner syndrome (TS) treated in Belgium with growth hormone between 1991 and 2002 was evaluated. 15723912 2005
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 GeneticVariation disease UNIPROT Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. 15863612 2005
Entrez Id: 7298
Gene Symbol: TYMS
TYMS
0.040 Biomarker disease BEFREE Amongst different cell lines examined, HCT-15 and normal fibroblasts showed no nuclear TS, HCC-2998 and SW-620 showed a small amount of nuclear TS, and HT-29, RKO, and HCT-116 showed a strong nuclear TS signal. 15956025 2006
Entrez Id: 5194
Gene Symbol: PEX13
PEX13
0.010 GeneticVariation disease BEFREE The immunofluorescent staining with anti-Pex13p antibody also revealed TS phenotype of the I326T mutant protein itself in the patient cells. 16006427 2005
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.010 AlteredExpression disease BEFREE The DU145 cell line harbors a TS mutant of p53 and, in addition to being a widely used model of human prostate carcinoma, may also reveal new insights into p53 function due to the unique transcriptional properties of its TS phenotype. 16741917 2006
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 GeneticVariation disease BEFREE Previous studies implicate CACNA1C (L-type Ca(V)1.2) calcium channel mutations in a disorder associated with autism (Timothy syndrome). 16754686 2006
Entrez Id: 7420
Gene Symbol: VDI
VDI
0.010 GeneticVariation disease BEFREE We found that the TS mutation powerfully and selectively slows VDI while sparing or possibly speeding the kinetics of CDI. 18250309 2008
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
1.000 GeneticVariation disease BEFREE The gene families and genetic lesions underlying familial hemiplegic migraine, FHM1/CACNA1A, FHM2/ATP1A2, and FHM3/SCN1A, and monogenic mitochondrial migraine syndromes, provide a robust platform from which genes, such as CACNA1C, which encodes the calcium channel mutated in Timothy syndrome, can be evaluated for their role in autism and bipolar disease. 19154521 2009
Entrez Id: 7298
Gene Symbol: TYMS
TYMS
0.040 GeneticVariation disease BEFREE However, the relationship between TS phenotype and TSER genotype in normal tissues warrants further investigations in large-scale prospective studies evaluating TS genotype and fluoropyrimidine tolerability. 19632929 2009
Entrez Id: 778
Gene Symbol: CACNA1F
CACNA1F
0.010 Biomarker disease BEFREE LTCC dysfunction can result from structural aberrations within their pore-forming alpha1 subunits causing hypokalemic periodic paralysis and malignant hyperthermia sensitivity (Cav1.1 alpha1), incomplete congenital stationary night blindness (CSNB2; Cav1.4 alpha1), and Timothy syndrome (Cav1.2 alpha1; reviewed separately in this issue). 20213496 2010
Entrez Id: 2688
Gene Symbol: GH1
GH1
0.030 GeneticVariation disease BEFREE Clinical data during rhGH treatment were compared in GH and TS patients with different genotypes. 21073120 2010